Blueprint Medicines Corporation - Common Stock (BPMC)
99.25
+9.75 (10.89%)
NASDAQ · Last Trade: May 2nd, 2:51 AM EDT
Via Benzinga · April 8, 2025
Via Benzinga · March 20, 2025
Via Benzinga · March 17, 2025

Via Benzinga · March 3, 2025

Via Benzinga · February 13, 2025

Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.
Via Benzinga · January 19, 2025

Via Benzinga · January 13, 2025

Why the high growth investor may take a look at BLUEPRINT MEDICINES CORP (NASDAQ:BPMC).
Via Chartmill · December 3, 2024

JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities.
Via Benzinga · November 14, 2024